Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $344,797 (100.0% shares, 0.0% debt)

Holdings (7)

MDXG MIMEDX GROUP, INC. 63.0%

Value ($000) $217,103 Shares 28,195,249 Est. Cost $7.32 Unrealized +9.8%

BVS BIOVENTUS 19.6%

Value ($000) $67,711 Shares 13,021,324 Est. Cost $13.37 Unrealized -63.4%

EYPT EYEPOINT PHARMACEUTICALS INC 9.3%

Value ($000) $32,070 Shares 1,551,521 Est. Cost $4.68 Unrealized +428.9%

TELA TELA BIO, INC. 6.8%

Value ($000) $23,308 Shares 4,110,709 Est. Cost $11.82 Unrealized -44.2%

— REVANCE THERAPEUTICS INC 0.7%

Value ($000) $2,249 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 0.5%

Value ($000) $1,604 Shares 1,105,941 Est. Cost $2.95 Unrealized -51.9%

— VENUS CONCEPT, INC. 0.2%

Value ($000) $753 Shares 1,089,190 Est. Cost $0.69 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	28,195,249	$217,103	63.0%	$7.32	+9.8%	COM	602496101
BVS	BIOVENTUS	13,021,324	$67,711	19.6%	$13.37	-63.4%	COM CL A	09075A108
EYPT	EYEPOINT PHARMACEUTICALS INC	1,551,521	$32,070	9.3%	$4.68	+428.9%	COM NEW	30233G209
TELA	TELA BIO, INC.	4,110,709	$23,308	6.8%	$11.82	-44.2%	COM	872381108
—	REVANCE THERAPEUTICS INC	457,085	$2,249	0.7%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$1,604	0.5%	$2.95	-51.9%	COM NEW	58468P206
—	VENUS CONCEPT, INC.	1,089,190	$753	0.2%	$0.69	—	COM	92332W204